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An implant-based breast reconstruction (IBBR) is by far the preferred way of restoring a fe-male breast after mastectomy and a 2-stage 
breast reconstruction, by means of a tissue expander, 
accounts for approximately 70% of all reconstruc-
tions according to the American Society of Plastic 
Surgeons statistics.1 Nonetheless, the  opportunity of 
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Background: Direct-to-implant breast reconstruction can be achieved more 
easily by means of soft-tissue replacement devices such as dermal matrices 
and synthetic meshes. The feasibility of a subcutaneous approach has been 
recently investigated by some studies with different devices functioning as 
implant support. Aim of this study is to analyze the long-term results, both 
objective and subjective, of a previous nonrandomized trial comparing pre-
pectoral (subcutaneous) and retropectoral breast reconstructions.
Methods: Patients enrolled in a nonrandomized prospective trial, compar-
ing the standard retropectoral reconstruction and the prepectoral subcu-
taneous approach, using a titanium-coated mesh in both techniques, were 
followed up and evaluated for long-term results. Cases were compared 
in terms of the causes and rate of reinterventions, of the postoperative 
BREAST-Q questionnaire results, and of an objective surgical evaluation.
Results: The subcutaneous group had a rate of implant failure and removal 
of 5.1% when compared with 0% in the retropectoral group. Aesthetic 
outcome was significantly better for the subcutaneous group both at a sub-
jective and at an objective evaluation. Capsular contracture rate was 0% in 
the subcutaneous group.
Conclusions: A higher rate of implant failure and removal, although not 
significant, always because of skin flaps and wound problems, should be 
taken into account for a careful patients selection. The subcutaneous breast 
reconstruction shows good long-term results. A coherent subjective and ob-
jective cosmetic advantage of this approach emerges. Moreover, no capsular 
contracture is evident, albeit in a relatively limited number of cases. (Plast 
Reconstr Surg Glob Open 2015;3:e574; doi: 10.1097/GOX.0000000000000533; 
Published online 8 December 2015.)
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a direct-to-implant breast reconstruction in breast 
surgical oncology is very fascinating and tempting for 
surgeons and for women as well. Whenever surgical 
conditions, tumor stage and adjuvant treatments al-
low this option, it is definitely worth considering the 
avoidance of a temporary tissue expander and its dis-
comfort.2 A 1-stage  procedure is quite demanding in 
technical terms. A full muscular pocket, to cover the 
prosthesis, allows the use of small to medium size im-
plants and sometimes does not let the surgeon recre-
ate a good lower pole shape and inframammary fold 
contour. The introduction of soft-tissue replacement 
devices in IBBR dramatically expands this field in 
breast surgery. Acellular dermal matrices (ADMs) are 
by far the most frequently used worldwide.3 A lot of 
data are present in literature for ADMs use in breast 
reconstruction.4–18 Synthetic meshes are used as well, 
as an alternative to ADMs. A titanium-coated poly-
propylene mesh (TCPM), TiLoop Bra (pfm medical, 
Cologne, Germany), is approved for use in breast sur-
gery in Europe since 2008. There are studies showing 
its safety and effectiveness in IBBR,19,20 with promis-
ing results in terms of capsular contracture.21
Soft-tissue replacement devices are traditionally 
used as an inferolateral extension of pectoralis major 
muscle. ADMs or synthetic meshes function as a ham-
mock to adjust an implant after its placement in a ret-
ropectoral position and after muscle detachment from 
its inferior aspect. Recently, a novel approach, with a 
prepectoral, subcutaneous, muscle-sparing implant po-
sitioning, has been described.22–24 In a previous study, 
we described a prospective nonrandomized clinical 
trial designed to compare a muscle-sparing method of 
using TCPM, as a complete coverage for a prepectoral 
implant, with the standard retropectoral muscular 
mesh implant coverage.22 Results are limited to a short-
term follow-up, with surgical complications and im-
plant loss showing no difference between the 2 groups.
Aim of this study is to analyze and evaluate long-
term results on the same patients enrolled in the afore-
mentioned trial, with 25 months of median follow-up. 
To ascertain reliability and quality of the subcutane-
ous reconstructions performed in the previous study, 
the analysis is focused on long-term surgical compli-
cations, requiring reintervention, along with objective 
parameters such as rippling, capsular contracture, and 
cosmetic outcome. Another primary endpoint of pres-
ent evaluation is women’s quality of life (QOL), ana-
lyzing functional and aesthetic subjective parameters.
PATIENTS	AND	METHODS
In 2011, a prospective nonrandomized clinical 
study was started to compare the use of TCPM in 
direct-to-implant reconstructions either in the stan-
dard muscular mesh implant coverage (group 1, G-1, 
breast implants in partial retropectoral position, with 
synthetic TCPM placed as a hammock-like elonga-
tion of the muscle over the inferolateral pole) or in 
a different muscle-sparing technique (group 2, G-2, 
totally subcutaneous, prepectoral implant adjust-
ment, wrapped in a TCPM bag). Enrollment ended in 
January 2014. Study design and surgical details were 
previously described.22 Briefly, inclusion criteria were 
age less than 80 years, normal body mass index (BMI; 
range, 18.5–24.9), small-to-medium size breasts, and 
ptosis grade of the first and second degree according 
to the 3-tier Regnault ptosis scale.25 Exclusion criteria 
were previous breast surgery, T4 and metastatic can-
cers, refusal to sign the consent, comorbidities (diabe-
tes, renal failure, congestive heart failure, pulmonary 
diseases, hypertension, chronic hepatic diseases, and 
metabolic diseases), smoking, and previous radio-
therapy to the chest wall. Cases baseline characteris-
tics and oncological data of the 2 groups are shown 
in Table 1. In May 2015, with a minimum follow-up of 
16 months from the last enrolled case, we proceeded 
to a surgical, functional, and aesthetic analysis of all 
cases. Patients were called and invited to participate 
in a long-term clinic evaluation. All patients signed 
a consent to accept the visit/questionnaire within a 
standard out-patient clinic scheduled activity. No ethi-
cal committee approval was required.
All further surgical procedures and postoperative 
radiation therapies, between the first reconstruction 
and last follow-up, were investigated and registered. 
Furthermore, both an objective and a subjective eval-
uation were conducted. All the evaluations started 
and were completed within May 2015. The subjec-
tive evaluation was conducted using the postopera-
tive section of BREAST-Q (Memorial Sloan-Kettering 
Cancer Center and The University of British Colum-
bia © 2006, all rights reserved). According to a recent 
study on long-term patient-reported QOL after breast 
implant reconstruction,26 the BREAST-Q reconstruc-
tion module was divided into multiple independent 
scales: satisfaction with breasts (16 items), satisfaction 
with outcome (7 items), psychosocial well being (10 
items), physical well being (16 items), and sexual well 
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being (6 items). For each scale, item responses were 
summed and transformed into a score, ranging from 
0 to 100. Higher scores indicate greater satisfaction or 
QOL. On the other hand, the objective evaluation was 
performed by 2 surgeons simultaneously. The evalu-
ating surgeons were staff members of the Breast Unit 
but not those who operated on the patients of the 
study. A 5-item form was fulfilled for every reconstruc-
tion case. The form was structured as follows: a, cap-
sular contracture evaluation, using the 4-grade Baker 
classification; b, registration of signs of rippling, using 
a 5-grade Likert scale (score: 1, strongly disagree; 2, 
disagree; 3, undecided; 4, agree; 5, strongly agree) 
to judge the statement “this case has no signs at all of 
rippling”; c, registration of signs of implant’s profile 
visibility, using a 5-grade Likert scale to judge the state-
ment “this case has no signs at all of a visible implant”; 
d, registration of signs of implant borders tangibility 
at smooth touch, using a 5-grade Likert scale to judge 
the statement “this case has no signs at all of palpable 
implant borders”; e, aesthetic result, judging the state-
ment “this case has an excellent aesthetic outcome,” 
still using a 5-grade Likert scale. This evaluation was 
conducted by 2 different surgeons at the same time, 
giving a single agreed score for every item.
Subjective evaluation was conducted by every sin-
gle patient, whereas the objective evaluation was per-
formed on every single operated breast, therefore, 
for both reconstructions in bilateral cases.
Statistical	Analysis
Comparison between muscular mesh pocket and 
mesh bag pocket patients was made by Wilcoxon’s 
rank sum test for continuous variables and χ2 test or 
Fisher’s exact test for categorical variables. BREAST-
Q scores were compared as a continuous variable. 
For each scale, we reported median, range, mean, 
and standard deviation of the score.
All statistical analyses were performed by STATA 
12.1 (StataCorp. 2011, Stata Statistical Software: Re-
lease 12, StataCorp LP, College Station, Tex.)
RESULTS
Twenty-nine patients had been initially enrolled 
in G-1 and 34 patients in G-2; there were 5 bilater-
al reconstructions in each group, meaning that an 
overall number of 34 cases in G-1 and 39 cases in G-2 
had been performed. Cases from the 2 groups were 
not significantly different in terms of type of inter-
vention (nipple-sparing mastectomy vs skin-sparing 
mastectomy), concurrent axillary lymph nodes dis-
section (ALND), preoperative chemotherapy, and 
postoperative radiation therapy (Table 1). One pa-
tient of G-2 died before this study and was not evalu-
ated. Therefore, 29 patients from G-1 and 33 patients 
from G-2 were invited and visited as for the purposes 
of this analysis. One patient in G-2 had her implant 
removed in the early postoperative course because 
of a large skin-flap necrosis (as reported in the previ-
ous study on short-term complications). Two more 
patients in G-2 had their implant removed later on 
because of wound dehiscence during chemotherapy 
in one case and ipsilateral chest wall local recurrence 
in the other. Because all these 3 cases had a differ-
ent type of reconstruction, with autologous flaps, 
they were not submitted to present study objective 
and subjective functional and aesthetic evaluation. 
Eventually, 29 (49%) patients, 34 (49%) cases, were 
evaluated from G-1 and 30 (51%) patients, 35 (51%) 
cases, from G-2, with 26 and 25 months of median 
follow-up, respectively. Early surgical complications 
from a previous study and long-term results with data 
analyses from this study are shown in Table 2.
DISCUSSION
Breast reconstruction is nowadays a goal that can 
be achieved more easily and with a much greater 
cosmetic satisfaction for both women and surgeons. 
An implant reconstruction is the preferred way of 
achieving such a result, and a 2-stage procedure is 
the commonest solution. A single-stage procedure 
Table 1. Demographics and Oncological Data of the 
2 Groups
Muscular	Mesh	
Pocket	G-1
Mesh	Bag	
	Pocket	G-2 P	Value
No. of cases 34 39
No. of patients 29 34
Bilateral intervention, 
No. of patients (%)
5 (17) 5 (15) 1.00
Age, median (range) 51 (27–69) 47 (31–76) 0.12
BMI, median (range) 23 (19–25) 23 (19–24) 0.11
Type of intervention,  
N (%)
  SSM 5 (15) 3 (8) 0.46
  NSM 29 (85) 36 (92)
ALND, No. of cases 
(%)
9 (26) 13 (33) 0.61
Pathology, No. of 
cases (%)
  pT0 4 (12) 11 (28) 0.12
  pTis 7 (20) 7 (18)
  pT1 19 (56) 18 (46)
  pT2 3 (9) 3 (8)
  pT3 1 (3) 0 (0)
  pN0 25 (73) 26 (66) 0.82
  pN1 6 (18) 8 (21)
  pN2 2 (6) 4 (10)
  pN3 1 (3) 1 (3)
Neoadjuvant 
 chemotherapy,  
No. of patients (%)
1 (3) 4 (10) 0.36
Post-op radiotherapy: 
No. of cases (%)
6 (21) 9 (26) 0.77
NSM, nipple-sparing mastectomy; SSM, skin-sparing mastectomy.
PRS Global Open • 2015
4
is an interesting option whenever anatomical and 
oncological characteristics allow it. In a recent 
study, the single-stage and 2-stage procedures are 
compared in terms of surgical complications and 
women’s satisfaction.27 Results show no differences 
in terms of surgical complications, but the single-
stage approach is associated with higher sexual 
well-being satisfaction, even though more than 80% 
of patients required reinterventions with additional 
surgical revisions.
Even in terms of costs, a 2013 study shows a slight 
advantage for the 1-stage procedure, although only 
during the first 18 months and without statistical 
significance.28 A 1-stage technique with a direct-to-
implant approach is, therefore, more often adapted 
particularly after the introduction of soft-tissue re-
placement devices such as ADMs and synthetic mesh-
es. The standard use of these entails their placement 
as an elongation of the pectoralis major muscle, previ-
ously detached from its inferior aspect. The implant 
Table 2. Short-Term Complications and Long-Term Results of Surgical, Subjective, and Objective Comparison 
of the 2 Groups
Muscular	Mesh	
Pocket	G-1
Mesh	Bag		
Pocket	G-2 P	Value
Early, short-term follow-up, complications
  No. of patients 29 34
  No. of cases 34 39
  Early overall complications, No. of cases (%) 3 (9) 3 (8) 0.59
  Implant loss 0 (0) 1 (3) 0.54
  Skin–nipple necrosis 0 (0) 1 (3) 0.54
  Seroma 0 (0) 0 (0) 1.00
  Wound dehiscence 1 (3) 0 (0) 0.47
  Wound-skin infection 2 (6) 0 (0) 0.22
  Hematoma 0 (0) 1 (3) 0.54
  Atopic reaction versus prosthesis 0 (0) 0 (0) 1.00
  Reoperation 0 (0) 1 (3) 0.54
Late, long-term follow-up, surgical, subjective and objective results
  No. of patients 29 33
  No. of cases 34 38
  Months of follow-up, median (range) 26 (16–42) 25 (16–40) 0.34
  Late reinterventions, No. of cases (%) 9 (26) 5 (13) 0.233
  Implant removal 0 (0) 2 (5)
  Nipple areola complex removal 1 (3) 0 (0)
  Implant change 4 (12) 0 (0)
  Fat graft over the implant 4 (12) 3 (8)
Subjective evaluation, BREAST-Q scores*
  No. of evaluated patients 29 30
  Satisfaction with breasts
   Mean (SD) 59 (21) 57 (22) 0.81
   Median (range) 58 (13–100) 63 (15–94)
  Satisfaction with outcome
   Mean (SD) 84 (28) 98 (9) 0.03
   Median (range) 100 (0–100) 100 (57–100)
  Psychosocial well being
   Mean (SD) 70 (23) 76 (25) 0.22
   Median (range) 75 (25–100) 85 (15–100)
  Physical well being
   Mean (SD) 92 (8) 93 (11) 0.71
   Median (range) 97 (69–100) 95 (52–100)
  Sexual well being
   Mean (SD) 54 (29) 58 (31) 0.45
   Median (range) 54 (0–100) 54 (4–100)
Objective evaluation
  No. of evaluated cases 34 35
  Capsular contracture (Baker scale)
   I (%) 26 (76) 35 (100) <0.01
   II (%) 4 (12) 0 (0)
   III (%) 2 (6) 0 (0)
   IV (%) 2 (6) 0 (0)
  Rippling: fairly or very evident (%) 5 (15) 3 (9) 0.48
  Visible implant: fairly or very evident (%) 6 (18) 2 (6) 0.15
  Palpable implant: fairly or very evident (%) 5 (15) 3 (9) 0.48
  Aesthetic result: “agree or strongly agree with an 
excellent aesthetic outcome,” n (%)
22 (65) 32 (91) <0.01
*For each scale, item responses were summed and transformed into a score, ranging from 0 to 100. Higher scores indicate greater satisfaction 
or QOL.
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is, hence, covered by the muscle on the medial-upper 
pole and by such devices on the inferolateral pole to 
better define the lower profile and inframammary 
fold contour. Based on the rationale that prosthetic 
devices are actually subcutaneous under the mastecto-
my flaps in all the inferolateral reconstructed breast, 
a complete subcutaneous approach can possibly be 
used in selected cases. The direct-to-implant subcu-
taneous reconstruction with a muscle-sparing tech-
nique, wrapping the implant entirely within a TCPM 
bag (Fig. 1) and placing it underneath skin flaps 
(Figs. 2, 3), is described in a previous study, which 
constitutes the background of this long-term analy-
sis.22 The subcutaneous procedure means shifting the 
position of the implant from a retropectoral site to a 
prepectoral one, as schematically shown in Figs. 4, 5.
The subcutaneous approach is described, shortly 
after our study,22 also in 2 more papers, although in 
a smaller number of cases and using ADMs as cover-
age for the implant.23,24 Results of our previously pub-
lished prospective nonrandomized clinical study are 
limited to short-term complications and show that 
there are no differences in terms of surgical compli-
cations between the 2 groups of patients.22 Studies on 
the subcutaneous approach conclude that it is safe 
Fig.1. implant preparation. complete implant wrapping by 
means of a tcPM.
Fig. 2. Subcutaneous implant positioning. the implant and 
the mesh are placed directly underneath the skin flaps in a 
prepectoral position.
Fig. 3. Subcutaneous implant fixation. Few interrupted 
stitches are placed between the mesh and the muscular fas-
cia to secure the implant in the desired position.
Fig. 4. retropectoral implant position. implant in the tradi-
tional retropectoral pocket created by dissecting the muscle 
from chest wall.
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and feasible. Unfortunately, so far, none of them pres-
ent long-term results. Moreover, few article deal with 
the QOL in terms of cosmetic outcomes of breast can-
cer survivors submitted to any type of reconstruction, 
as highlighted in a recent study.29 This study faces the 
issue of subjective cosmetic outcome in the restrict-
ed sample of breast cancer survivors enrolled in the 
previous trial comparing the prepectoral and retro-
pectoral breast reconstructions. In addition to the 
cosmetic aspect, a subjective functional evaluation (as 
part of BREAST-Q) and an objective assessment, from 
surgeons’ perspective, are considered too. Results 
show that in terms of long-term outcomes the muscle-
sparing technique has an encouraging performance.
First, it should be acknowledged that 1 late im-
plant failure and removal, because of poor incision 
borders healing during chemotherapy, was recorded 
in G-2. This, summed with 1 early implant loss from 
the short-term evaluation, makes a surgical failure 
rate for the subcutaneous technique of 2 out of 39 
cases (5.1%) versus 0% in the standard muscular 
mesh pocket group (G-1). The other registered im-
plant removal in G-2 was because of a locoregional 
chest wall recurrence.
Notwithstanding this difference in surgical fail-
ure, due in both cases to skin flaps and wound prob-
lems, the implant change rate for functional and 
aesthetic reasons definitely favors the subcutaneous 
technique with 4 cases (12%) and 0 cases (0%) for 
G-1 and G-2, respectively. A similar number of fat 
grafts over the implant procedures, to ameliorate 
the cosmetic outcome, were performed in the 2 
groups. In terms of subjective QOL parameters, the 
BREAST-Q evaluation gives a statistically significant 
difference in the “satisfaction with outcome” group 
of items, with the subcutaneous technique favored 
over the retropectoral one. In our opinion, this ex-
cellent result in the subjective satisfaction with re-
constructed breast is because of the more natural 
appearance that a subcutaneous implant entails. 
This approach, in fact, naturally recreates the innate 
ptosis of the breast, being the implant in the original 
anatomical position of the breast gland (Figs. 6–8).
Among the objective evaluation parameters, a 
significant difference is exhibited for the capsular 
contracture rate and for the aesthetic outcome. In 
Fig. 5. Prepectoral, subcutaneous, implant position. implant 
in the subcutaneous space, above the muscle, which is not 
dissected.
Fig. 6. Subcutaneous, muscle-sparing, direct-to-implant 
breast reconstruction. Unilateral breast reconstruction with-
out any surgical procedure on the contralateral side.
Fig. 7. Subcutaneous, muscle-sparing, direct-to-implant 
breast reconstruction. Unilateral breast reconstruction with-
out any surgical procedure on the contralateral side.
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both cases, the subcutaneous technique results are 
superior to the retropectoral standard procedure. 
As for the capsular contracture rate, a III–IV grade 
contracture is recorded in 4 (12%) G-1 cases, com-
pared with 0% in G-2. A theoretical explanation for 
such a good result in capsular contracture is that 
the subcutaneous approach avoids any mechanical 
stress over the implant and over its capsule as op-
posed to a retropectoral technique. This hypothesis 
is corroborated by a recent article showing a signifi-
cant difference in capsular thickness between tissue 
expanders placed subcutaneously and those placed 
in the standard submuscular position.30 Interest-
ingly, no grade III–IV capsular contractures were 
encountered in G-2 even considering that 9 (26%) 
cases in this group received a postoperative radia-
tion therapy. Furthermore, the chemically and bio-
logically inert nature of the titanium-coated mesh 
might play a role in this as hypothesized in a recent 
study.21 Synthetic mesh constitutes an interface be-
tween implant and skin flaps, recreating a new fascia 
and supporting the implant itself to prevent rota-
tions in the early postoperative course. The same 
goal can be achieved by ADMs as described in the 
aforementioned studies.23,24 A TCPM has a good 
flexibility, which helps in placement. Its loose knit-
work helps in fluids drainage, avoiding closed space. 
Moreover, the new fascia created by mesh integra-
tion within tissues appears very thin and soft when 
exposed (Figs. 9, 10). A formal histologic analysis 
of TCPM integration within tissues was performed 
in 1 study,21 with good results in terms of fibrosis 
and subsequent capsular contracture. Besides, costs 
are definitely lower for TCPM when compared with 
ADMs overall.
Nonetheless, a subcutaneous reconstruction can 
be done, as reported in the cited articles from dif-
ferent authors,23,24 with TCPM or ADMs alternatively 
and seemingly with good results in both cases.
The surgeons’ aesthetic outcome judgment is 
deemed excellent in 91% of G-2 cases versus 65% 
of G-1, and this is coherent with the women subjec-
tive evaluation, with a significant advantage of the 
Fig. 8. Subcutaneous, muscle-sparing, direct-to-implant 
breast reconstruction. Bilateral mastectomy with a bilateral 
direct-to-implant subcutaneous reconstruction using the 
same implant and technique on both sides.
Fig. 10. Microscopic appearance of titanium-coated synthet-
ic mesh integration within capsule. Fibrous capsule shows 
regular cystic spaces containing pale material consistent 
with the tcPM, surrounded by a mild chronic inflammatory 
response with histiocytes and foreign body giant cells. these 
elements are completely integrated within fibroblastic tissue.
Fig. 9. titanium-coated synthetic mesh integration within 
capsule. appearance of capsule during a second-stage pro-
cedure, after tissue expander removal of a reconstructed 
breast by means of a tcPM. the synthetic mesh results com-
pletely integrated within the capsule, which results in thin 
and soft tissues.
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subcutaneous approach. A retropectoral implant has 
the disadvantage of the muscle presence, which can 
retract or somehow flatten the implant itself, with 
high ridden breast appearance and unpleasant “ani-
mated” implants. A subcutaneous reconstruction, in-
stead, allows a more natural ptosis and appearance 
of the breast (See video, See Supplemental Digital 
Content 1, which displays cosmetic long-term result 
of a bilateral subcutaneous breast reconstruction, 
bilateral mastectomy with direct-to-implant subcuta-
neous breast reconstruction in a skinny woman, and 
appearance at 24 month follow-up, in a patient sub-
mitted to systemic adjuvant chemotherapy and post-
operative radiation therapy on the right side. This 
video is available in the “Related Videos” section of 
the full-text article on http://www.PRSGO.com or 
available at http://links.lww.com/PRSGO/A152).
On the other hand, it is important to highlight 
that a careful patients selection is mandatory for a 
subcutaneous approach. The absence of muscle cov-
erage over the implant can expose the medial aspect 
of the reconstructed breast to more visible implant 
borders and signs of rippling. These drawbacks can 
be corrected with a fat graft procedure over the im-
plant capsule, as occurred in 3 cases (9%) in G-2. 
The surgeon choice of the subcutaneous technique 
over the submuscular one can be made intraopera-
tively on the basis of skin flaps viability and thickness. 
Also the reconstructed breast medial-upper aspect 
and sternal border contour is deemed important in 
the decision of using or sparing the muscle. A BMI 
lower than 18.5 was an exclusion criterion in patients 
enrollment. Nonetheless, even with normal BMI pa-
tients, in case of skinny flaps on the upper/medial 
pole of the reconstructed breast, a submuscular ap-
proach might be chosen if implant borders visibility 
and some ripples are predictable.
Some oncological aspects are of utmost impor-
tance as well, in the surgical planning beforehand. 
In case, if a postoperative radiation, and a chemo-
therapy as well, is anticipated, which could jeopar-
dize a correct wound and skin flaps healing, then a 
subcutaneous approach and maybe the entire direct-
to-implant reconstruction strategy would be better 
changed.
All results are limited by the number of cases and 
by the nonrandomization nature of the previous 
study upon which this long-term analysis was con-
ducted. Further analysis and larger numbers should 
be used to confirm present results. Nonetheless, this 
is, to our knowledge, the first study evaluating the 
subcutaneous approach with a median follow-up of 
25 months.
In conclusion, subcutaneous breast reconstruc-
tion exhibits encouraging results in terms of aes-
thetic outcome and capsular contracture over a 
long-term period of evaluation. Skin flaps viability 
and wound healing are of utmost importance for its 
successful performance. Present results might lead 
to a consideration of the muscle-sparing subcutane-
ous approach as a valid alternative to the standard 
retropectoral technique. As much as conservative, 
mastectomies31 have changed the breast surgical 
oncology scenario, a “conservative reconstruction” 
paradigm is worth considering.
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